Brian G Mitchell
Overview
Explore the profile of Brian G Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song J, Eyabi J, Awatramani P, Mitchell B, Nene S
Prim Care Companion CNS Disord
. 2024 Apr;
26(2).
PMID: 38621222
No abstract available.
2.
Jones G, Mitchell B, Bernard J, Walder A, Okusaga O
Prim Care Companion CNS Disord
. 2022 Nov;
24(6).
PMID: 36343352
To evaluate whether a history of suicide attempt increases the odds of receiving clozapine treatment in veterans with schizophrenia or schizoaffective disorder. Electronic health record data were obtained for veterans...
3.
Stark K, Basit S, Mitchell B
Fed Pract
. 2022 Apr;
39(3):130-135.
PMID: 35444394
Background: Lithium has known antisuicidal properties making it an important agent to study in veterans with psychiatric conditions, a population at high risk for suicide. Methods: A single-site, retrospective chart...
4.
Okusaga O, Kember R, Peloso G, Peterson R, Vujkovic M, Mitchell B, et al.
Complex Psychiatry
. 2022 Feb;
392:1789-1795.
PMID: 35128521
Introduction: Relative to the general population, patients with schizophrenia or schizoaffective disorder have higher rates of suicide attempts and mortality from COVID-19 infection. Therefore, determining whether a history of suicide...
5.
Okusaga O, Mitchell B, Bernard J, Walder A
J Clin Psychiatry
. 2021 Aug;
82(5).
PMID: 34428355
No abstract available.
6.
Stewart H, Mitchell B, Ayanga D, Walder A
Ment Health Clin
. 2021 May;
11(3):194-199.
PMID: 34026395
Introduction: AUD medication treatment has been shown to improve outcomes compared with placebo when confined to per-protocol analysis. The same outcomes, however, have not always been maintained in intent-to-treat analysis,...
7.
Mitchell B, Lee J
J Psychoactive Drugs
. 2021 Apr;
53(4):373-377.
PMID: 33814003
Clonidine is a centrally acting alpha-2 selective adrenergic receptor agonist used to treat hypertension and to control or prevent withdrawal in patients with opioid and alcohol use disorders. Case reports...
8.
Rozea H, Mitchell B, Miller L
J Clin Psychopharmacol
. 2020 Aug;
40(5):513-515.
PMID: 32796390
No abstract available.
9.
Lake E, Mitchell B, Shorter D, Kosten T, Domingo C, Walder A
Am J Addict
. 2019 Jan;
28(2):86-91.
PMID: 30664299
Background And Objectives: The core pharmacological treatment of Post-Traumatic Stress Disorder (PTSD) is selective serotonin reuptake inhibitors (SSRIs), although remission is only around 30% with them. Many patients will self-treat...
10.
Mitchell B, McMahon B, Mitchell C
Prim Care Companion CNS Disord
. 2017 Dec;
19(6).
PMID: 29195036
No abstract available.